EUVIMEDEUVIMED entdecken
Crossref

Vonoprazan versus Proton Pump Inhibitors for Helicobacter pylori Eradication in Peptic Ulcer Disease

Suhena Sarkar, Birupaksha Biswas, Biyanka Sau, Roshni Banerjee

International Journal of Drug Delivery Technology · 30.05.2026 · 16 (37s)

DOI: 10.25258/ijddt.16.37s.129 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 30.05.2026. Verfasst von Suhena Sarkar und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Context: Increasing antimicrobial resistance has reduced the effectiveness of proton pump inhibitor based regimens for Helicobacter pylori associated peptic ulcer disease. Vonoprazan produces more sustained acid suppression and may improve eradication outcomes.

Purpose

To compare the clinical efficacy of vonoprazan based triple therapy with conventional proton pump inhibitor based triple therapy.

Methods

In this observational comparative study, 80 adults with endoscopically confirmed peptic ulcer disease and documented H. pylori infection received triple therapy containing either vonoprazan or a proton pump inhibitor with identical antibiotics. Primary outcomes were H. pylori eradication and ulcer healing at 8 weeks. Secondary outcomes included changes in gastrointestinal symptom rating scale and QLICD scores.

Findings

Eradication was achieved in 86.8% of patients receiving vonoprazan and 61.9% receiving proton pump inhibitor therapy. Ulcer healing occurred in 89.5% and 73.8%, respectively. Vonoprazan was associated with greater symptom improvement, higher quality of life scores, and shorter median healing time.

Conclusion

Vonoprazan based therapy was associated with superior microbiologic eradication, faster mucosal recovery, and better patient reported outcomes than conventional acid suppressive therapy.

Zitieren

APA

Sarkar, S., Biswas, B., Sau, B., & Banerjee, R. (2026). Vonoprazan versus Proton Pump Inhibitors for Helicobacter pylori Eradication in Peptic Ulcer Disease. International Journal of Drug Delivery Technology, 16(37s). https://doi.org/10.25258/ijddt.16.37s.129

Vancouver

Sarkar S, Biswas B, Sau B, Banerjee R. Vonoprazan versus Proton Pump Inhibitors for Helicobacter pylori Eradication in Peptic Ulcer Disease. International Journal of Drug Delivery Technology. 2026;16(37s). doi:10.25258/ijddt.16.37s.129

BibTeX
@article{Sarkar2026,
  author = {Sarkar, Suhena and Biswas, Birupaksha and Sau, Biyanka and Banerjee, Roshni},
  title = {Vonoprazan versus Proton Pump Inhibitors for Helicobacter pylori Eradication in Peptic Ulcer Disease},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {37s},
  doi = {10.25258/ijddt.16.37s.129}
}
Kostenlos starten →